Cancer Cachexia: Clinical Trials

7 trials for Cancer Cachexia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 7

Follow Cancer Cachexia: new trials by email Literature Review of Cancer Cachexia trials Research Report on Cancer Cachexia

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy
SAT-003 - Cancer Cachexia
Not applicableCompletedS-Alpha Therapeutics, Inc.152023-07-112025-07-17
EXPLORING the IMPACT of SUPERVISED PHYSICAL ACTIVITY INTERVENTION on CACHECTIC CANCER PATIENTS: a PRELIMINARY STUDY
Adapted Physical Activity - Cancer Cachexia
Not applicableCompletedUniversity of Rennes 2232020-11-012024-10-21
PSYCHO-EDUCATIONAL AND REHABILITATIVE INTERVENTION FOR CANCER CACHEXIA (PRICC)
Psychoeducational and rehabilitative intervention - Cancer Cachexia
Not applicableCompletedAzienda USL Reggio Emilia - IRCCS242019-03-012025-06-12
Vitamin D for Muscle Metabolic Function in Cancer Cachexia
Vitamin D, Placebo - Cancer Cachexia, Vitamin D Deficiency
Not applicableCompletedDavid Travis Thomas12018-05-232020-10-14
Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients
Cannabics capsules - Cancer Cachexia, Atypical Anorexia Nervosa
Not applicableCompletedCannabics Pharmaceuticals Inc.242016-11-012018-04-10
Effects of WB-EMS and Dietetic Treatment on Cancer Patients
Whole-Body Electromyostimulation (WB-EMS) - Cancer, Cancer Cachexia
Not applicableCompletedUniversity of Erlangen-Nürnberg Medical School2782013-08-012018-10-16
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
Eicosapentaenoic Acid - Cancer Cachexia
Not applicableCompletedH. Lee Moffitt Cancer Center and Research Institute362007-07-012017-03-23

Narrower conditions

Cachexia (1)  ·  Motor Activity (1)  ·  Muscle Weakness (1)  ·  Muscular Atrophy (1)  ·  Neoplasms (1)  ·  Vitamin D Deficiency (1)  ·  Weight Loss (1)

Broader conditions

Atrophy (1)  ·  Avitaminosis (1)  ·  Behavior (1)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)

Interventions

Docosahexaenoic Acids (1)  ·  Eicosapentaenoic Acid (1)  ·  Omacor (1)  ·  Vitamin D (1)

Sponsors

Azienda USL Reggio Emilia - IRCCS (1)  ·  Cannabics Pharmaceuticals Inc. (1)  ·  David Travis Thomas (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  S-Alpha Therapeutics, Inc. (1)  ·  University of Erlangen-Nürnberg Medical School (1)  ·  University of Rennes 2 (1)

Countries

United States (2)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  South Korea (1)

Top investigators

Dalyong Kim, M.D., Ph.D (1)  ·  Gil Bar-Sela, Md (1)  ·  Loredana Buonaccorso, Dr. (1)  ·  Nagi Kumar, Ph.D. (1)

Results publications

PMID 30208857, PMID 30618820, PMID 31595793, PMID 33649057, PMID 37046724, PMID 42053853